Anterior thoracic spinal fusion in dogs by injection of recombinant human bone morphogenetic protein-2 and a synthetic polymer

Journal of Spinal Disorders and Techniques

Volumn 16, Issue 2, 2003, Pages 137-143

  Takahashi, Jun ^a   Saito, Naoto ^a   Ebara, Sohei ^a   Kinoshita, Tetsuya ^a   Itoh, Hidehiro ^a   Okada, Takao ^b   Nozaki, Kazutoshi ^c   Takaoka, Kunio ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Taki Chemical Co Ltd   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Injection; Polylactic acid polyethylene glycol (PLA PEG) block copolymer; Recombinant human bone morphogenetic protein 2 (rhBMP 2); Spinal fusion

Indexed keywords

COPOLYMER; MACROGOL; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; POLYMER;

ANIMAL EXPERIMENT; ANTERIOR SPINE FUSION; ARTICLE; CALLUS; CONTROLLED STUDY; DOG; HISTOLOGY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THORACIC SPINE; TREATMENT OUTCOME; IMPLANT;

EID: 0037382964     PISSN: 15360652     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024720-200304000-00004     Document Type: Article

References (25)

1. Farey ID, McAfee PC, Gurr KR, et al. Quantitative histologic study of the influence of spinal instrumentation on lumbar fusions: a canine model. J Orthop Res 1989;7:709-22.
2. Steinmann JC, Herkowitz HN. Pseudarthrosis of the spine. Clin Orthop 1992;284:80-90.
3. Conaty JP, Mongan ES. Cervical fusion in rheumatoid arthritis. J Bone Joint Surg Am 1981;63:1218-27.
4. Ferlic DC, Clayton ML, Leidholt JD, et al. Surgical treatment of the symptomatic unstable cervical spine in rheumatoid arthritis. J Bone Joint Surg Am 1975;57:349-54.
5. Zoma A, Sturrock RD, Fisher WD, et al. Surgical stabilization of the rheumatoid cervical spine. J Bone Joint Surg Br 1987;49:8-12.
6. Kurz LT, Garfin, SR, Booth RE Jr. Harvesting autogenous iliac bone grafts: a review of complications and techniques. Spine 1989;14:1324-31.
7. Ebara S, Kamimura M, Itoh H, et al. A new system for the anterior restoration and fixation of thoracic spinal deformities using an endoscopic approach. Spine 2000;25:876-83.
8. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-7.
9. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-4.
10. Boden SD, Moskovitz PA, Morone MA, et al. Video-assisted lateral intertransverse process arthrodesis: validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models. Spine 1996;21:1689-97.
11. Itoh H, Ebara S, Kamimura M, et al. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999;24:1402-5.
12. Boden SD, Martin GJ, Horton WC, et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cages. J Spinal Disord 1998;11:95-101.
13. Boden SD, Schimandle JH, Hutton WC. Evaluation of a bovine-derived osteoinductive bone protein extract in a non-human primate model of lumbar spinal fusion. Transactions of the 42nd Annual Meeting of the Orthopaedic Research Meeting, Atlanta, Georgia, February 19. 1996, 21:118.
14. Zdeblick TA, Ghanayem AJ, Rapoff AJ, et al. Cervical interbody fusion cages: an animal model with and without bone morphogenetic protein. Spine 1998;23:758-65.
15. Cunningham BW, Kanayama M, Parker LM, et al. Osteogenetic protein versus autologous interbody arthrodesis in the sheep thoracic spine: a comparative endoscopic study using the Bagby and Kuslich interbody fusion device. Spine 1999;24:509-18.
16. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81.
17. Miyamoto S, Takaoka K, Okada T, et al. Polylactic acid-polyethylene glycol block copolymer: a new biodegradable synthetic carrier for bone morphogenetic protein. Clin Orthop 1993;294:333-43.
18. Miyamoto S, Takaoka K, Okada T, et al. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin Orthop 1992;278:274-85.
19. Saito N, Okada T, Horiuchi H, et al. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 2001;19:332-5.
20. Saito N, Okada T, Horiuchi H, et al. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg Am 2001;83:92-8.
21. Saito N, Okada T, Toba S, et al. New synthetic absorbable polymers as BMP-carries: plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. J Biomed Mater Res 1999;47:104-10.
22. Takaoka K, Miyamoto S, Saito N, et al. In: Wise DL, et al., ed. New synthetic degradable polymers as carrier materials for BMP. Biomaterials Engineering and Devices: Human Applications, vol. 1. Totowa, NJ: Human Press.
23. Boden SD, Schimandle JH, Hutton WC, et al. 1995 Volvo Award in Basic Sciences. The use of an osteoinductive growth factor for lumbar spinal fusion: the biology of spinal fusion. Spine 1995;20:2626-32.
24. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2). Spine 1995;20:1326-37.
25. Izawa H, Hachiya Y, Kawai T, et al. The effect of heat-treated human bone morphogenetic protein on clinical implantation. Clin Orthop 2001;390:252-8.